Showing results (81-90 of 194) with videos related to
Sort By:
Pageof 20
Japanese Journal of Cancer Research : Gann|September 1, 1994
Detection of HTLV-II-seropositive blood donors in South Vietnam but not in North VietnamS Yamamoto, S Nakata, T Nakasone, et al.Proceedings of the National Academy of Sciences of the United States of America|July 22, 2020
Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserineMichael N Trinh, Michael S Brown, Joseph L Goldstein, et al.Journal of Gastroenterology and Hepatology|November 22, 2011
Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to actionRobert G Gish, Tam D Bui, Chuc T K Nguyen, et al.European Journal of Gastroenterology & Hepatology|April 29, 2015
Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapyLily H Kim, Kevin T Chaung, Nghiem B Ha, et al.Alimentary Pharmacology & Therapeutics|July 2, 2016
Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infectionL H Nguyen, J Hoang, N H Nguyen, et al.Digestive Diseases and Sciences|June 1, 2021
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBVDavid E Bernstein, Huy N Trinh, Eugene R Schiff, et al.Organic & Biomolecular Chemistry|June 9, 2016
Quinolone-1-(2H)-ones as hedgehog signalling pathway inhibitorsTrieu N Trinh, Eileen A McLaughlin, Mohammed K Abdel-Hamid, et al.Alimentary Pharmacology & Therapeutics|August 3, 2011
The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofirE Sheen, H N Trinh, T T Nguyen, et al.Cancer Research|April 1, 2010
Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancerBo Young Ahn, Adam N Elwi, Byoungchun Lee, et al.European Journal of Gastroenterology & Hepatology|November 22, 2012
Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practiceAnne Liu, Nghiem B Ha, Brian Lin, et al.Pageof 20